131 Phase I/II efficacy and safety study of mesenchymal stromal cells in recessive dystrophic epidermolysis bullosa

Authors :: María José Escámez
R. Maseda
John A. McGrath
R. de Lucas
Su M. Lwin
Marta García
M. Del Rio
E. Chacón-Solano
Sara García-Barcenilla
Lucía Martínez-Santamaría
Source :: Journal of Investigative Dermatology. 139:S236
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pathology
medicine.medical_specialty
Phase i ii
business.industry
Recessive dystrophic epidermolysis bullosa
Mesenchymal stem cell
Medicine
Cell Biology
Dermatology
business
Molecular Biology
Biochemistry

Tools